TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020

Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide.

Mallika P Patel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.